Aristippos Gennadios - Aug 23, 2023 Form 4/A - Amendment Insider Report for Catalent, Inc. (CTLT)

Role
Group Pres. Pharma & Consumer
Signature
/s/ Amy Fallone, attorney-in-fact
Stock symbol
CTLT
Transactions as of
Aug 23, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/12/2023, 07:07 PM
Date Of Original Report
Aug 25, 2023
Previous filing
Aug 3, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Other $0 -1.59K -1.65% $0.00 95K Aug 23, 2023 Direct F1, F2
transaction CTLT Common Stock Other +396 +0.42% 95.4K Aug 24, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to reflect the reversal of the acquisition of shares received by the reporting person upon the achievement of the fiscal 2021-23 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan, as reported in the original form 4 filed on August 25, 2023 (the "Original Form 4"). Due to the ongoing review of the Issuer's fiscal 2021-23 performance-based vesting criteria, the Compensation and Leadership Committee of the Issuer rescinded its prior approval of the vesting criteria and confirmed that the reporting person had no right to the shares previously reported on the Original Form 4.
F2 Includes restricted stock units.
F3 This amendment is also being filed to reflect the reversal of the disposition of shares sold by the reporting person through an automatic "sell to cover" transaction in order to cover tax withholding obligations in connection with the vesting of performance share units pursuant to the Issuer's long-term incentive plan, as reported on the Original Form 4.